Versant Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16	Closed	-$3K	–	1673
2021 Q2	$3K	Sell	16 -21	-57%	-$3.6K	﹤0.01%	1090
2021 Q1	$6K	Buy	37 +6	+19%	+$928	﹤0.01%	992
2020 Q4	$4K	Hold	31	–	–	﹤0.01%	1021
2020 Q3	$3K	Hold	31	–	–	﹤0.01%	1033
2020 Q2	$3K	Hold	31	–	–	﹤0.01%	1022
2020 Q1	$2K	Sell	31 -6	-16%	-$589	﹤0.01%	1078
2019 Q4	$4K	Sell	37 -2	-5%	-$214	﹤0.01%	1040
2019 Q3	$3K	Hold	39	–	–	﹤0.01%	1127
2019 Q2	$5K	Sell	39 -101	-72%	-$13K	﹤0.01%	985
2019 Q1	$18K	Sell	140 -11	-7%	-$1.37K	0.01%	679
2018 Q4	$14K	Hold	151	–	–	0.01%	704
2018 Q3	$20K	Hold	151	–	–	0.01%	653
2018 Q2	$18K	Hold	151	–	–	0.01%	678
2018 Q1	$16K	Sell	151 -14	-8%	-$1.67K	0.01%	728
2017 Q4	$19K	Hold	165	–	–	0.01%	693
2017 Q3	$23K	Sell	165 -17	-9%	-$2.31K	0.01%	545
2017 Q2	$22K	Hold	182	–	–	0.01%	567
2017 Q1	$22K	Hold	182	–	–	0.01%	556
2016 Q4	$22K	Sell	182 -69	-27%	-$8.44K	0.01%	563
2016 Q3	$30K	Sell	251 -6	-2%	-$772	0.02%	433
2016 Q2	$30K	Sell	257 -7	-3%	-$993	0.02%	396
2016 Q1	$36K	Sell	264 -6	-2%	-$881	0.02%	323
2015 Q4	$51K	Buy	+270	New	+$47.2K	0.03%	226

Other funds holding ALXN